News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Cawkwell Gail
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/05/2023 |
4
| Cawkwell Gail (Chief Medical Officer) has filed a Form 4 on Aclaris Therapeutics, Inc.
Txns:
| Paid exercise price by delivering 5,407 shares
@ $10.37, valued at
$56.1k
Exercised 15,000 restricted stock units
@ $0 |
|
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/15/2022 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 320 shares
@ $15.8, valued at
$5.1k
|
|
01/31/2022 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 6,600 shares
@ $0 Granted 11,300 options to buy
@ $14.44, valued at
$163.2k
|
|
01/04/2022 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 2,455 shares
@ $16.29, valued at
$40k
|
|
11/16/2021 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $19.04, valued at
$6.1k
|
|
05/13/2021 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $17.75, valued at
$5.7k
|
|
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/16/2020 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $38.52, valued at
$12.3k
|
|
08/14/2020 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $53.44, valued at
$17k
|
|
05/14/2020 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $89.05, valued at
$28.4k
|
|
02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/27/2020 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 4,200 shares
@ $0 Granted 6,900 options to buy
@ $99.66, valued at
$687.7k
|
|
01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/05/2019 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Exercised 80 options to buy
@ $54.63, valued at
$4.4k
|
|
11/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/14/2019 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 319 shares
@ $86.66, valued at
$27.6k
|
|
04/22/2019 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Exercised 1,750 options to buy
@ $54.63, valued at
$95.6k
|
|
02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/18/2019 |
4
| Cawkwell Gail (SVP, Med Affairs, Safety & PV) has filed a Form 4 on INTERCEPT PHARMACEUTICALS, INC.
Txns:
| Granted 4,100 shares
@ $0 Granted 6,700 options to buy
@ $110.8, valued at
$742.4k
|
|
|
|